In this context, our results suggest that AD 198 targets c-Myc by inhibiting c-Myc transcription in tumor B cells, which is mediated through inhibition of ERK, p38 and JNK pathways as well as activation of the Akt pathway. This evidence concerns the gene MYC and neoplasm.